Financials
Financial year 2025
Dr. Jos Van Acker - Klinische Biologie from Gent, company number BE0477493782, closed financial year 2025 with a result of € 758,597 after tax. For that financial year Dr. Jos Van Acker - Klinische Biologie recorded a gross margin of € 834,871 and equity of € 4.2 million. Compared with financial year 2024, the result moved from € 701,029 to € 758,597. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.
€ 4.2 million
▼ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 758,597
▲ 8% vs 2024
Profit after tax over the fiscal year.
€ 197,304
▼ 42% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.8 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 7,281
▼ 14% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 301,297
Loans from banks and other lenders, long and short.
€ 3,555
▲ € 3,387 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 87,482
▼ 11% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 856,691 | € 713,530 | € 750,199 | € 834,871 | ▲ 11% |
| Profit after taxes | € 403,131 | € 499,475 | € 701,029 | € 758,597 | ▲ 8% |
| Equity | € 4,016,454 | € 4,515,929 | € 5,216,958 | € 4,187,446 | ▼ 20% |
| Total debts | € 236,257 | € 389,828 | € 441,165 | € 427,037 | ▼ 3% |
| Cash | € 401,046 | € 162,118 | € 337,733 | € 197,304 | ▼ 42% |
| Land & buildings | € 59,153 | € 734,576 | € 709,843 | € 685,110 | ▼ 3% |
| Retained profit | € 3,997,854 | € 4,497,329 | € 5,198,358 | € 4,168,846 | ▼ 20% |
| Dividend | € 0 | € 0 | € 0 | € 1,788,108 | |
| Bank debt | € 4,260 | € 300,881 | € 302,349 | € 301,297 | |
| Balance sheet total | € 4,252,711 | € 4,905,757 | € 5,658,122 | € 4,614,483 | ▼ 18% |
Key figures of Dr. Jos Van Acker - Klinische Biologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Dr. Jos Van Acker - Klinische Biologie?
What happened at Dr. Jos Van Acker - Klinische Biologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 758,597 (▲ 8% vs 2024). Source: NBB ↗
- Jos Van Acker became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 403,131 profit in 2022 to € 758,597 profit in 2025.
Paid € 958,644 in corporate taxes since 2022.
Best year ever: 2025, with € 758,597 profit.
Paid out € 1.8 million in dividends to the owners in total.
Management
Behind Dr. Jos Van Acker - Klinische Biologie is Jos Van Acker.
Directors
According to the 2025 annual accounts
Jos Van Acker
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Pekelharing 53
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0477.493.782
- VAT number
- BE 0477.493.782
- Registered office
- Pekelharing 53, 9000 Gent
- Names & denominations
- Dr. Jos Van Acker - Klinische Biologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 May 2002
- Peppol
- Active · Active since 22 Sept 2025